University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 17 of 35
Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men
NCT03143205
The Relation of GnRH Treatment to QTc Interval in Transgender Females
NCT03078829
Women's Lifestyle Balance Study
NCT03184337
Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients
NCT03006913
Survivor Choices for Eating and Drinking - Colorectal Cancer
NCT02965521
Cardiac Recovery Through Dietary Support
NCT03759925
Improving Preterm Infant Outcomes With Family Integrated Care and Mobile Technology
NCT03418870
Preoperative Guided Imagery in Patients Undergoing Urologic Surgery
NCT05072639
Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial
NCT02950480
Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults
NCT03078816
Health Coaching for Positive Airway Pressure Adherence
NCT04067128
Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation
NCT03136068
Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger
NCT03207711
Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD
NCT02975505
Mobile-based Peer Mentoring for Smoking Cessation
NCT03048786
I-scan for Adenoma Detection
NCT02811419
Learning From Online Video Education for Controlled Ovarian Stimulation
NCT02979990
Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine
NCT04310462
Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors
NCT02947373
Regional Anesthesia (Supra-Orbital and Infra-Orbital Nerve Block) (SION) for Pain Management in Trans-sphenoidal Hypophysectomy
NCT04670614
Predictors of Outcomes in MBSR Participants From Teacher Factors
NCT03384771
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
NCT02602327
Progression and Etiology of Cortical Porosity in Diabetic Bone Disease
NCT04208230
Oxytocin HIV Meth Study
NCT02881177
Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)
NCT02791542
Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma
NCT02548598
Characterizing the Synergistic Effects of Physical and Cognitive Training on Attention and Working Memory
NCT03032796
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263
Interventions To Help Asthma Clinical Adherence
NCT02999789
Improving Mental Health and Well-Being Via Awe Walks
NCT03550144
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
NCT03208920
Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications
NCT02062008
The Share Health Study: Teen Social Connections and Health
NCT02791971
Improving Engagement in HIV Care for High-risk Women
NCT03081559
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
NCT02956278
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
NCT02806024
Interactive Mobile Doctor (iMD) for Asian Smokers
NCT02966132
Health Outcomes Patient Education
NCT02976220
Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair
NCT02825849
MRI With C13 Pilot Study Prostate Cancer
NCT02450201
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
NCT02866695
A Study of Oxidative Pathways in MS Fatigue
NCT02804594
Enhancing Self-Management Support in Diabetes Through Patient Engagement
NCT02834923
Research on Expecting Moms and Sleep Therapy
NCT02805998
Immunologic Response to Secukinumab in Plaque Psoriasis
NCT02592018
Emotion Tracking Study for Residents
NCT02947477
Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation
NCT02802176
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients
NCT02919111
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
NCT02918357
Integrative Approaches For Cancer Survivorship 2: Project 1
NCT02897635
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.